Citius Pharmaceuticals, Inc. (CTXR)
0.8877
-0.01
(-1.37%)
USD |
NASDAQ |
Jan 09, 16:00
0.8686
-0.02
(-2.15%)
After-Hours: 20:00
Citius Pharmaceuticals EPS Diluted (Quarterly): -0.4405 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Oncology, Inc. | -0.0617 |
| Dynavax Technologies Corp. | 0.2063 |
| Applied Therapeutics, Inc. | -0.1305 |
| Dermata Therapeutics, Inc. | -1.648 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.744M |
| Total Expenses (Quarterly) | 7.959M |
| Enterprise Value | 25.97M |
| Earnings Yield | -429.8% |
| Normalized Earnings Yield | -429.75 |